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Idiopathic ventricular ﬁbrillation is a major clinical and
diagnostic challenge. Because the heart is structurally normal
and a culprit gene defect is not identiﬁed in the proband,
family members cannot undergo clinical or genetic risk
stratiﬁcation. With low overall survival from ventricular
ﬁbrillation and small numbers of subjects available for study,
traditional kindred-based approaches for identiﬁcation of
novel genes are low yield in idiopathic ventricular ﬁbrillation.
Whole exome sequencing has emerged as a complementary
approach for the identiﬁcation of genetic variants associated
with inherited human diseases. In this issue of the Journal,See page 259Marsman et al. (1) report on their use of whole exome
sequencing for investigation of genetic defects in 2 affected
siblings presenting with idiopathic ventricular ﬁbrillation and
early onset sudden cardiac death (SCD). They identiﬁed
a missense variant within calmodulin 1 (CALM1) associated
with idiopathic ventricular ﬁbrillation and SCD in childhood
and adolescence. These ﬁndings are clearly of immediate
clinical relevance to the extended family members of these
2 subjects, as they ﬁnally provide the means to assess SCD
risk among yet unaffected individuals.
This new information also represents another important
chink in the armor of idiopathic ventricular ﬁbrillation,
which is slowly yet steadily yielding to better-deﬁned primary
arrhythmia syndromes such as the long-QT syndrome,
Brugada syndrome, and catecholaminergic polymorphic
ventricular tachycardia. Calmodulins are proteins with
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and a large number of proteins regulated by calcium (2).
Interestingly, mutations in CALM1 and CALM2 have
been previously implicated in primary arrhythmia disorders
(3,4). Nyegaard et al. (3) identiﬁed 2 missense mutations: the
ﬁrst mutation was Asn53Ile in a large Swedish family that
presented with well-documented catecholaminergic poly-
morphic ventricular tachycardia, and a second de novo
mutation, Asn97Ser, was identiﬁed in a subject of Iraqi
origin. Functional characterization of these variants showed a
signiﬁcant reduction in Ca2þ afﬁnity, and for the Asn97Ser,
an aberrant interaction with the RYR2 receptor at low
calcium concentrations (3). Crotti et al. (4) performed whole
exome sequencing in 4 subjects presenting with recurrent
cardiac arrest and neurodevelopmental delay in early infancy.
They found 3 mutations within CALM1 and CALM2 and
showed that all 3 mutations have reduced Ca2þ afﬁnity in the
C domain (4). The paper by Marsman et al. (1) provides
additional evidence for the role of calmodulin mutations
in familial arrhythmia disorders, this time due to a novel,
presumably causal mutation (Phe90Leu) resulting in idio-
pathic ventricular ﬁbrillation and early onset SCD. However,
there is an important caveat to keep in mind. The 2 subjects
who survived idiopathic ventricular ﬁbrillation, as well as
their mother, had mild QT prolongation with exercise.
Because electrocardiographic recordings are not available for
the extended family, it is difﬁcult to rule out long-QT syn-
drome with certainty. The authors did not perform func-
tional characterization of the Phe90Leu variant. However,
there is previous evidence suggesting that alterations of
phenylalanine residues in calmodulin may have a speciﬁc role
in calcium binding activation (5,6). Nonetheless, further
work is needed to evaluate the role of Phe90Leu in additional
families presenting with idiopathic ventricular ﬁbrillation.
Different mutations in the same gene could lead to different
molecular mechanisms, as pointed out by the authors. Thus,
calmodulins are attractive candidate genes for the investiga-
tion of molecular pathways associated with arrhythmias. In
addition, CALM1 has been nominally associated with severe
coronary artery disease (7) and stroke (8), leaving open the
tantalizing possibility that calmodulins may be involved in
more common, complex forms of ventricular arrhythmias,
such as those associated with coronary artery disease.
While diagnosis by whole exome sequencing holds pro-
mise, what will it take for this tool to be incorporated into
mainstream clinical practice? The process of whole exome
sequencing provides a generous list of candidates that need to
be “ﬁltered” to identify a shortlist that eventually leads to
a single gene variant. This process is currently labor intensive,
with at least some likelihood of a false positive result, but
improvements in ongoing analysis software are likely to have
a favorable impact on the efﬁciency and speciﬁcity of whole
exome sequencing. As whole exome sequencing provides
more candidate gene variants in abundance, the ﬁeld will
need to keep up with evaluation of the functional signiﬁcance
of these variants in order to establish a pathophysiological
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from the ENCODE consortia highlight the importance of
noncoding regions in human diseases (9), but exome se-
quencing covers only coding regions, representing about
1.2% of the human genome. However, in addition to its use
as a diagnostic tool, there are emerging examples of utili-
zing whole exome sequencing for precision therapeutics.
Worthey et al. (10) diagnosed a child with X-linked apo-
ptosis deﬁciency by identifying a missense mutation within
NOD2. This ﬁnding allowed the clinicians to design a
speciﬁc treatment based on bone marrow transplantation.
Marsman et al. (1) are to be commended for their careful
approach. Their ﬁndings highlight the promise of whole
exome sequencing to make a diagnosis, even among small
numbers of affected subjects in families with inherited sudden
death syndromes. They have contributed to the under-
standing of idiopathic ventricular ﬁbrillation while providing
additional evidence for the role of CALM1 in ventricular
arrhythmias and sudden death. It would be important to
evaluate these ﬁndings in other families with idiopathic
ventricular ﬁbrillation and to also assess the speciﬁc func-
tional role of the culprit genetic mutation they have identiﬁed.
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